PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Laboratory Medicine, Carl-Thiem-Hospital Cottbus, Cottbus, Germany; Institute of Biological Chemistry, Biophysics and Bioengineering School of Engineering and Physical Sciences, Heriot-Watt University, Riccarton, Edinburgh EH144AS, Scotland, UK.\', \'Institute of Microbiology and Hospital Hygiene, Carl-Thiem-Hospital Cottbus, Cottbus, Germany.\', \'Dept. of Neurology, Carl-Thiem-Hospital Cottbus, Cottbus, Germany.\', \'Dept. of Neurology, Universitymedicine Greifswald, Greifswald Germany.\', \'Clinical Trials Unit, Carl-Thiem-Hospital Cottbus, Cottbus, Germany.\', \'Institute of Laboratory Medicine, Carl-Thiem-Hospital Cottbus, Cottbus, Germany.\', \'Dept. of Neurology, Carl-Thiem-Hospital Cottbus, Cottbus, Germany. Electronic address: a.dressel@ctk.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2211-0348(22)00069-410.1016/j.msard.2022.103554
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 35180617
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all